Difference between revisions of "Template:Diuretics"
Jump to navigation
Jump to search
imported>Whoop whoop pull up |
(added indacrinone) |
||
| (30 intermediate revisions by 20 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Diuretics |
| − | | title = [[ | + | | title = [[Diuretic]]s ([[ATC code C03|C03]]) |
| − | | | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | | | + | | listclass = hlist |
| + | | group1 = [[Sulfonamide (medicine)|Sulfonamide]]s<br />(and [[etacrynic acid]]) | ||
| + | | list1 = {{Navbox|child | ||
| − | + | | group1 = [[Carbonic anhydrase inhibitor|CA inhibitor]]s (at [[Proximal tubule|PT]]) | |
| − | + | | list1 = | |
| − | |||
| − | |||
| − | |||
| − | |||
* [[Acetazolamide]] | * [[Acetazolamide]] | ||
| − | | group2 = [[Loop diuretic|Loop]] ([[Na-K-Cl cotransporter|Na-K-Cl]] at [[Thick ascending limb of loop of Henle|AL]]) | + | | group2 = [[Loop diuretic|Loop]] ([[Na-K-Cl cotransporter|Na-K-Cl]] at [[Thick ascending limb of loop of Henle|AL]]) |
| − | | list2 | + | | list2 = |
* [[Furosemide]]<sup>#</sup> | * [[Furosemide]]<sup>#</sup> | ||
| + | * [[Azosemide]] | ||
* [[Bumetanide]] | * [[Bumetanide]] | ||
* [[Etacrynic acid]] | * [[Etacrynic acid]] | ||
| − | * [[ | + | * [[Etozolin]] |
| + | * [[Indacrinone]] | ||
* [[Muzolimine]] | * [[Muzolimine]] | ||
| + | * [[Ozolinone]] | ||
* [[Piretanide]] | * [[Piretanide]] | ||
* [[Tienilic acid]] | * [[Tienilic acid]] | ||
* [[Torasemide]] | * [[Torasemide]] | ||
| − | + | | group3 = [[Thiazide]]s ([[Sodium-chloride symporter|Na-Cl]] at [[Distal convoluted tubule|DCT]],<br />[[Diuretic#Calcium-sparing diuretics|Calcium-sparing]]) | |
| − | + | | list3 = | |
| − | * [[ | + | * [[Altizide]] |
* [[Bendroflumethiazide]] | * [[Bendroflumethiazide]] | ||
| − | * [[ | + | * [[Butizide]] |
* [[Chlorothiazide]] | * [[Chlorothiazide]] | ||
| − | |||
| − | |||
* [[Cyclopenthiazide]] | * [[Cyclopenthiazide]] | ||
| − | |||
* [[Cyclothiazide]] | * [[Cyclothiazide]] | ||
| + | * [[Epitizide]] | ||
| + | * [[Hydrochlorothiazide]]<sup>#</sup> | ||
| + | * [[Hydroflumethiazide]] | ||
* [[Mebutizide]] | * [[Mebutizide]] | ||
| + | * [[Methyclothiazide]] | ||
| + | * [[Polythiazide]] | ||
| + | * [[Trichlormethiazide]] | ||
| − | + | | group4 = [[Thiazide-like diuretic|Thiazide-like]]s (primarily [[Distal convoluted tubule|DCT]]) | |
| − | + | | list4 = | |
* [[Quinethazone]] | * [[Quinethazone]] | ||
* [[Clopamide]] | * [[Clopamide]] | ||
| Line 52: | Line 56: | ||
* [[Fenquizone]] | * [[Fenquizone]] | ||
| + | }} | ||
| − | + | | group2 = [[Potassium-sparing diuretic|Potassium-sparing]] (at [[Collecting duct system|CD]]) | |
| − | + | | list2 = {{Navbox|child | |
| − | |||
| − | | | ||
| − | | group1 = [[Epithelial sodium channel blocker|ESC blockers]] | + | | group1 = [[Epithelial sodium channel blocker|ESC blockers]] |
| − | | list1 | + | | list1 = |
* [[Amiloride]]<sup>#</sup> | * [[Amiloride]]<sup>#</sup> | ||
* [[Triamterene]] | * [[Triamterene]] | ||
* [[Benzamil]] | * [[Benzamil]] | ||
| − | | group2 = [[Aldosterone antagonist]]s | + | | group2 = [[Antimineralocorticoid|Aldosterone antagonist]]s |
| − | | list2 | + | | list2 = |
| − | * [[Spironolactone]]<sup>#</sup> | + | * ''[[Spirolactone]]s'' |
| − | * [[Eplerenone]] | + | ** [[Spironolactone]]<sup>#</sup> |
| − | * [[Potassium canrenoate]] | + | ** [[Eplerenone]] |
| − | * [[Canrenone]] | + | ** [[Potassium canrenoate]] |
| + | ** [[Canrenone]] | ||
| − | + | * ''[[Nonsteroidal]]'' | |
| + | ** [[Finerenone]] | ||
| + | }} | ||
| − | + | | group3 = [[Osmotic diuretic]]s ([[Proximal tubule|PT]], [[Descending limb of loop of Henle|DL]]) | |
| − | + | | list3 = | |
* [[Mannitol]]<sup>#</sup> | * [[Mannitol]]<sup>#</sup> | ||
| + | * [[Glycerol]] | ||
* [[Urea]] | * [[Urea]] | ||
| − | + | | group4 = [[Vasopressin receptor antagonist|Vasopressin receptor inhibitor]]s<br />([[Distal convoluted tubule|DCT]] and [[Collecting duct|CD]]) | |
| − | + | | list4 = | |
| − | * ''[[Vasopressin receptor antagonist#Vaptans| | + | * ''[[Vasopressin receptor antagonist#Vaptans|Vaptans]]'' |
| − | * [[Mozavaptan]] | + | ** [[Conivaptan]] |
| − | * [[Satavaptan]] | + | ** [[Mozavaptan]] |
| − | * [[Tolvaptan]] | + | ** [[Satavaptan]] |
| + | ** [[Tolvaptan]] | ||
| − | * ''[[Vasopressin receptor antagonist# | + | * ''[[Vasopressin receptor antagonist#Demeclocycline and lithium|Others]]'' |
| + | ** [[Demeclocycline]] | ||
| + | ** [[Lithium carbonate]] | ||
| − | + | | group5 = Other | |
| − | + | | list5 = | |
| − | * ''[[mercurial diuretic]]'' ([[Mersalyl]], [[Meralluride]]) | + | * [[Ethanol]], [[Isopropanol]], [[tert-Amyl alcohol|2M2B]] |
| + | * ''[[mercurial diuretic]]s'' ([[Chlormerodrin]], [[Mersalyl]], [[Meralluride]]) | ||
* [[Theobromine]] | * [[Theobromine]] | ||
* [[Cicletanine]] | * [[Cicletanine]] | ||
| − | | | + | | group6 = Combination products |
| − | | | + | | list6 = |
| + | * [[Hydrochlorothiazide/triamterene]] | ||
| + | |||
| + | | group7 = | ||
| − | | belowstyle = background: transparent; padding: 0px; | + | | belowstyle = background: transparent; padding: 0px; |
| − | | below = {{PharmNavFootnote | + | | below = {{PharmNavFootnote}} |
}}<noinclude> | }}<noinclude> | ||
| − | + | {{collapsible option}} | |
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
</noinclude> | </noinclude> | ||
Latest revision as of 11:35, 2 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Diuretics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Diuretics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Diuretics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.